Aug 19 |
Pipeline Moves: Moderna’s pandemic influenza vaccine trial completes
|
Aug 19 |
Pfizer and BioNTech's Combo Shot Missed the Mark. Is It Time to Sell?
|
Aug 17 |
FDA is said to clear updated COVID shots as early as next week
|
Aug 16 |
Pfizer, BioNTech hit roadblock in COVID-flu vaccine trial
|
Aug 16 |
Pfizer’s Stumble on Flu and Covid Shot Is a Plus for Moderna
|
Aug 16 |
Pfizer and Moderna Covid-19 vaccines usage and updated safety labels
|
Aug 15 |
Moderna, Inc. (NASDAQ:MRNA) is a favorite amongst institutional investors who own 67%
|
Aug 14 |
Moderna and Coursera Launch Free Course on mRNA Technology
|
Aug 13 |
Struggling COVID-19 Vaccines From AstraZeneca, BioNTech/Pfizer, Moderna Cut Incidence Of Arterial Thromboses That Cause Heart Attacks, Strokes, British Study Shows
|
Aug 13 |
Long Covid Remains Diagnostic Mystery, Diagnosis Remains Elusive; National Institutes of Health-Funded Study Shows
|